Chunxia Shi

1.2k total citations · 1 hit paper
39 papers, 865 citations indexed

About

Chunxia Shi is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Chunxia Shi has authored 39 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Chunxia Shi's work include Liver Disease Diagnosis and Treatment (10 papers), Inflammasome and immune disorders (7 papers) and Mitochondrial Function and Pathology (5 papers). Chunxia Shi is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Inflammasome and immune disorders (7 papers) and Mitochondrial Function and Pathology (5 papers). Chunxia Shi collaborates with scholars based in China, United States and United Kingdom. Chunxia Shi's co-authors include Zuojiong Gong, Yao Wang, Fangzhou Jiao, Qian Chen, Luwen Wang, Maohua Pei, Pan Cao, Danmei Zhang, Haiyue Zhang and Qingqi Zhang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Chunxia Shi

39 papers receiving 860 citations

Hit Papers

PANoptosis: A Cell Death Characterized by Pyroptosis, Apo... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunxia Shi China 16 466 211 161 124 108 39 865
Yan Shen China 16 343 0.7× 159 0.8× 165 1.0× 80 0.6× 176 1.6× 42 1.1k
Shanmei Shen China 24 485 1.0× 331 1.6× 137 0.9× 70 0.6× 70 0.6× 70 1.7k
Zhongxin Li China 20 637 1.4× 82 0.4× 170 1.1× 105 0.8× 196 1.8× 67 1.2k
Rui Yu China 19 416 0.9× 212 1.0× 60 0.4× 172 1.4× 158 1.5× 52 1.1k
Chunling Huang China 21 565 1.2× 162 0.8× 91 0.6× 118 1.0× 92 0.9× 56 1.1k
Xuemei Gu China 17 390 0.8× 236 1.1× 120 0.7× 44 0.4× 69 0.6× 40 1.0k
Rohit Sahai India 9 425 0.9× 201 1.0× 427 2.7× 61 0.5× 74 0.7× 10 1.2k
Honglan Zhou China 17 609 1.3× 132 0.6× 89 0.6× 193 1.6× 149 1.4× 67 1.2k

Countries citing papers authored by Chunxia Shi

Since Specialization
Citations

This map shows the geographic impact of Chunxia Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Shi more than expected).

Fields of papers citing papers by Chunxia Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Shi. The network helps show where Chunxia Shi may publish in the future.

Co-authorship network of co-authors of Chunxia Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Chunxia Shi. A scholar is included among the top collaborators of Chunxia Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunxia Shi. Chunxia Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yukun, Danmei Zhang, Chunxia Shi, et al.. (2025). The FMO3/TMAO/HSP90β axis aggravates MAFLD by disrupting mitochondrial protein homeostasis. Cellular Signalling. 134. 111960–111960. 1 indexed citations
2.
Wang, Yukun, Chunxia Shi, Danmei Zhang, et al.. (2024). Mitochondrial calcium uniporter complex: Unveiling the interplay between its regulators and calcium homeostasis. Cellular Signalling. 121. 111284–111284. 5 indexed citations
3.
Wang, Lei, et al.. (2024). Impact of Dexmedetomidine Dosing and Timing on Acute Kidney Injury and Renal Outcomes After Cardiac Surgery: A Meta-Analytic Approach. Annals of Pharmacotherapy. 59(4). 319–329. 2 indexed citations
4.
Zhang, Danmei, et al.. (2024). MPO-DNA Complexes and cf-DNA in Patients with Sepsis and Their Clinical Value. Biomedicines. 12(10). 2190–2190. 5 indexed citations
5.
Shi, Chunxia, et al.. (2024). Deacetylated MDH1 and IDH1 aggravates PANoptosis in acute liver failure through endoplasmic reticulum stress signaling. Cell Death Discovery. 10(1). 275–275. 12 indexed citations
6.
Zhang, Qingqi, Chunxia Shi, Danmei Zhang, et al.. (2024). The SIRT2-AMPK axis regulates autophagy induced by acute liver failure. Scientific Reports. 14(1). 16278–16278. 3 indexed citations
7.
Wang, Yukun, Chunxia Shi, Jin Guo, et al.. (2024). IDH1/MDH1 deacetylation promotes acute liver failure by regulating NETosis. Cellular & Molecular Biology Letters. 29(1). 8–8. 15 indexed citations
8.
Zhang, Qingqi, Qian Chen, Pan Cao, et al.. (2023). AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway. Hepatobiliary & pancreatic diseases international. 23(1). 43–51. 8 indexed citations
9.
Zhang, Yanqiong, Chunxia Shi, Danmei Zhang, et al.. (2023). Sulforaphane, an NRF2 agonist, alleviates ferroptosis in acute liver failure by regulating HDAC6 activity. Journal of Integrative Medicine. 21(5). 464–473. 17 indexed citations
10.
Zhang, Danmei, Chunxia Shi, Qingqi Zhang, et al.. (2023). Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death. Journal of Inflammation. 20(1). 24–24. 2 indexed citations
11.
Shi, Chunxia, Fangzhou Jiao, Yao Wang, et al.. (2022). SIRT3 inhibitor 3-TYP exacerbates thioacetamide-induced hepatic injury in mice. Frontiers in Physiology. 13. 915193–915193. 10 indexed citations
12.
Cao, Pan, Qian Chen, Chunxia Shi, Lu-Wen Wang, & Zuojiong Gong. (2022). Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World Journal of Gastroenterology. 28(17). 1798–1813. 7 indexed citations
13.
Shi, Chunxia, Zugui Zhang, David Li, et al.. (2022). Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes. BMC Anesthesiology. 22(1). 122–122. 1 indexed citations
14.
Jiao, Fangzhou, Yao Wang, Qian Chen, et al.. (2021). Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome. Oxidative Medicine and Cellular Longevity. 2021(1). 5522708–5522708. 13 indexed citations
15.
Shi, Chunxia, Yao Wang, Fangzhou Jiao, et al.. (2021). Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation. Frontiers in Physiology. 12. 683526–683526. 8 indexed citations
16.
Cao, Pan, Qian Chen, Chunxia Shi, et al.. (2021). Pinocembrin ameliorates acute liver failure via activating the Sirt1/PPARα pathway in vitro and in vivo. European Journal of Pharmacology. 915. 174610–174610. 12 indexed citations
17.
Wang, Yao, Haiyue Zhang, Qian Chen, et al.. (2020). TNF‐α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Proliferation. 53(6). e12829–e12829. 157 indexed citations
18.
Shi, Chunxia, Yao Wang, Qian Chen, et al.. (2020). Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways. Frontiers in Cellular and Infection Microbiology. 10. 196–196. 39 indexed citations
19.
Chen, Qian, et al.. (2019). Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure. Life Sciences. 238. 116976–116976. 12 indexed citations
20.
Jiao, Fangzhou, Yao Wang, Wenbin Zhang, et al.. (2019). Protective role of AGK2 on thioacetamide-induced acute liver failure in mice. Life Sciences. 230. 68–75. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026